RT @GSCollins: @dnunan79 @EQUATORNetwork @MaartenvSmeden Prognostic models is TRIPOD (https://t.co/5ZbnfYod2u). Prognostic factors REMARK…
RT @GSCollins: @dnunan79 @EQUATORNetwork @MaartenvSmeden Prognostic models is TRIPOD (https://t.co/5ZbnfYod2u). Prognostic factors REMARK…
RT @GSCollins: @dnunan79 @EQUATORNetwork @MaartenvSmeden Prognostic models is TRIPOD (https://t.co/5ZbnfYod2u). Prognostic factors REMARK…
RT @GSCollins: @dnunan79 @EQUATORNetwork @MaartenvSmeden Prognostic models is TRIPOD (https://t.co/5ZbnfYod2u). Prognostic factors REMARK…
Twitter at it's best.
RT @GSCollins: @dnunan79 @EQUATORNetwork @MaartenvSmeden Prognostic models is TRIPOD (https://t.co/5ZbnfYod2u). Prognostic factors REMARK…
@dnunan79 @EQUATORNetwork @MaartenvSmeden Prognostic models is TRIPOD (https://t.co/5ZbnfYod2u). Prognostic factors REMARK (https://t.co/x6Iav2JQ68). Genetic risk prediction GRIPS (https://t.co/PY0Q3FkpeK CHARMS for models (https://t.co/Gh8GHe0aPv) CHARM
Willi Sauerbrei #REWARD2020 talking about a neglected area of reporting: statistical analyses. The E&E paper for the REMARK guideline for tumour marker prognostic studies tried to help with a detailed breakdown of the item on analysis: https://t.co/ooS
RT @GSCollins: @kdpsinghlab @TRIPODStatement Thanks, some work has started on something similar to this (as yet unpublished) but also summa…
@kdpsinghlab @TRIPODStatement Thanks, some work has started on something similar to this (as yet unpublished) but also summarising the model building/validation steps, based on the REMARK profile (for tumour markers), see Table 2 (https://t.co/6sbvcgI2HW)
#bmcmedicine Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration http://t.co/d5HAph4Q
Altman et al. explain & elaborate upon the original #REMARKguidelines for proper reporting of #prognostic #tumormarkers http://t.co/uhH9JbIj